{"pmid":32361194,"title":"Molecular mimicry between SARS-CoV-2 and respiratory pacemaker neurons.","text":["Molecular mimicry between SARS-CoV-2 and respiratory pacemaker neurons.","Autoimmun Rev","Lucchese, Guglielmo","Floel, Agnes","32361194"],"journal":"Autoimmun Rev","authors":["Lucchese, Guglielmo","Floel, Agnes"],"date":"2020-05-04T11:00:00Z","year":2020,"_id":"32361194","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1016/j.autrev.2020.102556","topics":["Treatment","Mechanism"],"weight":1,"_version_":1666138495536594944,"score":9.490897,"similar":[{"pmid":32453861,"title":"Is molecular mimicry the culprit in the autoimmune hemolytic anemia affecting COVID-19 patients?","text":["Is molecular mimicry the culprit in the autoimmune hemolytic anemia affecting COVID-19 patients?","This Journal recently published two papers describing autoimmune hemolytic anemia (AIHA) associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (1, 2). AIHA is characterized by the destruction of red cells by autoantibodies, but the mechanism underpinning autoimmunity in COVID-19 patients has yet to be elucidated.","Br J Haematol","Angileri, Francesca","Legare, Sebastien","Marino Gammazza, Antonella","Conway de Macario, Everly","Macario, Alberto Jl","Cappello, Francesco","32453861"],"abstract":["This Journal recently published two papers describing autoimmune hemolytic anemia (AIHA) associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (1, 2). AIHA is characterized by the destruction of red cells by autoantibodies, but the mechanism underpinning autoimmunity in COVID-19 patients has yet to be elucidated."],"journal":"Br J Haematol","authors":["Angileri, Francesca","Legare, Sebastien","Marino Gammazza, Antonella","Conway de Macario, Everly","Macario, Alberto Jl","Cappello, Francesco"],"date":"2020-05-27T11:00:00Z","year":2020,"_id":"32453861","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1111/bjh.16883","keywords":["ankirin 1","autoantibodies","autoimmunity","covid-19","molecular mimicry","severe acute respiratory syndrome coronavirus 2"],"topics":["Mechanism"],"weight":1,"_version_":1667983494521815040,"score":53.437748},{"pmid":32389543,"title":"COVID-19 and molecular mimicry: The Columbus' egg?","text":["COVID-19 and molecular mimicry: The Columbus' egg?","J Clin Neurosci","Cappello, Francesco","32389543"],"journal":"J Clin Neurosci","authors":["Cappello, Francesco"],"date":"2020-05-12T11:00:00Z","year":2020,"_id":"32389543","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.jocn.2020.05.015","weight":0,"_version_":1666528580008411136,"score":52.971577},{"pmid":32314313,"pmcid":"PMC7192985","title":"Is COVID-19 a proteiform disease inducing also molecular mimicry phenomena?","text":["Is COVID-19 a proteiform disease inducing also molecular mimicry phenomena?","Cell Stress Chaperones","Cappello, Francesco","32314313"],"journal":"Cell Stress Chaperones","authors":["Cappello, Francesco"],"date":"2020-04-22T11:00:00Z","year":2020,"_id":"32314313","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1007/s12192-020-01112-1","weight":0,"_version_":1666138493453074435,"score":47.514946},{"pmid":32497778,"title":"A pharmacological interactome between COVID-19 patient samples and human sensory neurons reveals potential drivers of neurogenic pulmonary dysfunction.","text":["A pharmacological interactome between COVID-19 patient samples and human sensory neurons reveals potential drivers of neurogenic pulmonary dysfunction.","The SARS-CoV-2 virus infects cells of the airway and lungs in humans causing the disease COVID-19. This disease is characterized by cough, shortness of breath, and in severe cases causes pneumonia and acute respiratory distress syndrome (ARDS) which can be fatal. Bronchial alveolar lavage fluid (BALF) and plasma from mild and severe cases of COVID-19 have been profiled using protein measurements and bulk and single cell RNA sequencing. Onset of pneumonia and ARDS can be rapid in COVID-19, suggesting a potential neuronal involvement in pathology and mortality. We hypothesized that SARS-CoV-2 infection drives changes in immune cell-derived factors that then interact with receptors expressed by the sensory neuronal innervation of the lung to further promote important aspects of disease severity, including ARDS. We sought to quantify how immune cells might interact with sensory innervation of the lung in COVID-19 using published data from patients, existing RNA sequencing datasets from human dorsal root ganglion neurons and other sources, and a genome-wide ligand-receptor pair database curated for pharmacological interactions relevant for neuro-immune interactions. Our findings reveal a landscape of ligand-receptor interactions in the lung caused by SARS-CoV-2 viral infection and point to potential interventions to reduce the burden of neurogenic inflammation in COVID-19 pulmonary disease. In particular, our work highlights opportunities for clinical trials with existing or under development rheumatoid arthritis and other (e.g. CCL2, CCR5 or EGFR inhibitors) drugs to treat high risk or severe COVID-19 cases.","Brain Behav Immun","Ray, Pradipta R","Wangzhou, Andi","Ghneim, Nizar","Yousuf, Muhammad S","Paige, Candler","Tavares-Ferreira, Diana","Mwirigi, Juliet M","Shiers, Stephanie","Sankaranarayanan, Ishwarya","McFarland, Amelia J","Neerukonda, Sanjay V","Davidson, Steve","Dussor, Gregory","Burton, Michael D","Price, Theodore J","32497778"],"abstract":["The SARS-CoV-2 virus infects cells of the airway and lungs in humans causing the disease COVID-19. This disease is characterized by cough, shortness of breath, and in severe cases causes pneumonia and acute respiratory distress syndrome (ARDS) which can be fatal. Bronchial alveolar lavage fluid (BALF) and plasma from mild and severe cases of COVID-19 have been profiled using protein measurements and bulk and single cell RNA sequencing. Onset of pneumonia and ARDS can be rapid in COVID-19, suggesting a potential neuronal involvement in pathology and mortality. We hypothesized that SARS-CoV-2 infection drives changes in immune cell-derived factors that then interact with receptors expressed by the sensory neuronal innervation of the lung to further promote important aspects of disease severity, including ARDS. We sought to quantify how immune cells might interact with sensory innervation of the lung in COVID-19 using published data from patients, existing RNA sequencing datasets from human dorsal root ganglion neurons and other sources, and a genome-wide ligand-receptor pair database curated for pharmacological interactions relevant for neuro-immune interactions. Our findings reveal a landscape of ligand-receptor interactions in the lung caused by SARS-CoV-2 viral infection and point to potential interventions to reduce the burden of neurogenic inflammation in COVID-19 pulmonary disease. In particular, our work highlights opportunities for clinical trials with existing or under development rheumatoid arthritis and other (e.g. CCL2, CCR5 or EGFR inhibitors) drugs to treat high risk or severe COVID-19 cases."],"journal":"Brain Behav Immun","authors":["Ray, Pradipta R","Wangzhou, Andi","Ghneim, Nizar","Yousuf, Muhammad S","Paige, Candler","Tavares-Ferreira, Diana","Mwirigi, Juliet M","Shiers, Stephanie","Sankaranarayanan, Ishwarya","McFarland, Amelia J","Neerukonda, Sanjay V","Davidson, Steve","Dussor, Gregory","Burton, Michael D","Price, Theodore J"],"date":"2020-06-05T11:00:00Z","year":2020,"_id":"32497778","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1016/j.bbi.2020.05.078","locations":["ligand"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1668712823876747264,"score":43.304436}]}